连续性血液净化治疗脓毒血症及并发MODS后临床疗效观察
Clinical Observation of Continuous Blood Purification in the Treatment of Sepsis and Complicated with MODS
摘要: 目的:探讨连续性血液净化治疗脓毒血症及并发多器官功能不全综合征(MODS)后临床疗效。方法:2011年6月至2016年6月期间,选择在本院接受治疗的脓毒血症患者例进行研究,其中将未并发多器官功能不全综合征患者82例作为对照组,将并发多器官功能不全综合征患者102例作为观察组,均行连续性血液净化治疗,观察治疗效果。结果:治疗前两组患者平均动脉压、呼吸频率、心率及血氧饱和度比较无明显差异,P > 0.05;治疗后,对照组各指标明显改善,且改善程度显著优于观察组,P < 0.05。治疗前两组患者ALT、Scr、TNF-α、IL-1、IL-8等指标比较无明显差异,P > 0.05;治疗后观察组患者各项实验室指标均改善,但效果较对照组差,组间比较差异明显,P < 0.05。结论:采用连续性血液净化治疗脓毒血症及并发多器官功能不全综合征患者可有效稳定身体状态和炎性指标,但仍需注意应尽早结合其病情实施个性化综合治疗,预防脓毒血症并发多器官功能不全综合征,尽早控制病情,改善健康状态。
Abstract: Objective: To investigate the clinical effect of continuous blood purification in the treatment of sepsis and multiple organ dysfunction syndrome (MODS). Methods: From June 2011 to June 2016, 82 patients with sepsis who received treatment in our hospital were selected as the control group. 102 patients with multiple organ dysfunction syndrome were treated with continuous blood puri-fication. Results: There was no significant difference in mean arterial pressure, respiratory rate, heart rate and oxygen saturation between the two groups before treatment (P > 0). After treatment, the indexes of the control group were obviously improved, and the degree of improvement was significantly better than that of the observation group (P < 0.05). Before treatment, there was no significant difference between the two groups (P > 0.05), but all the laboratory indexes in the observation group were improved, but the effect was worse than that in the control group, and the difference between the two groups was significant (P < 0.05). Conclusion: Continuous blood puri-fication for patients with sepsis and complicated multiple organ dysfunction syndrome can effec-tively stabilize the body state and inflammatory index, but it is still necessary to pay attention to the combination of the disease as soon as possible to implement personalized comprehensive treatment to prevent sepsis complicated by multiple organ dysfunction syndrome, early control the disease and improve health.
文章引用:周红超. 连续性血液净化治疗脓毒血症及并发MODS后临床疗效观察[J]. 护理学, 2019, 8(3): 258-262. https://doi.org/10.12677/NS.2019.83049

参考文献

[1] 李苗苗, 薛晓艳, 贺小旭. 连续性血液净化治疗脓毒血症及并发MODS后临床疗效观察[J]. 中国急救复苏与灾害医学杂志, 2016, 11(2): 119-122.
[2] 宋家志, 张毅. 连续性血液净化治疗尿脓毒血症导致多器官功能障碍综合征16例临床探讨[J]. 医学信息, 2016, 29(12): 144-145.
[3] 汪永斌, 姬晓伟, 占林兵, 等. 连续性血液净化治疗29例重症脓毒血症的疗效观察[J]. 中华全科医学, 2016, 14(4): 580-582.
[4] 罗家庆. 连续性血液净化应用于ICU重症脓毒血症治疗临床疗效及安全性评价[J]. 中国实用医药, 2016, 11(9): 124-125.
[5] 刘卫明, 金同新, 陆逢时, 等. 高容量连续性血液净化(CBP)治疗脓毒血症并急性肾损伤的临床疗效[J]. 辽宁医学杂志, 2017, 31(2): 9-11.
[6] 杨业龙. 连续性血液净化治疗重症脓毒血症的临床效果观察[J]. 基层医学论坛, 2016, 20(36): 5093-5094.
[7] 黄小甜. 连续性血液净化治疗ICU重症脓毒血症的临床疗效及安全性评价[J]. 齐齐哈尔医学院学报, 2017, 38(18): 2150-2151.
[8] 陈伟, 胡志华, 杨远征. 乌司他丁辅助高容量血液滤过对严重脓毒血症血清细胞黏附分子-1、胆碱酯酶和凝血功能的影响[J]. 中国现代医学杂志, 2016, 26(11): 54-58.
[9] 韩宇, 张素梅, 施锐. 乌司他丁联合胸腺肽对脓毒血症患者免疫调理的临床研究[J]. 河北医学, 2016, 22(9): 1409-1411.
[10] 朱建军. 脓毒血症患者抗凝治疗对凝血和炎性指标的影响研究[J]. 临床医学工程, 2016, 23(3): 353-354.
[11] 刘静, 王芳. 连续性血液净化治疗重症脓毒血症患者的护理[J]. 中国继续医学教育, 2017, 9(19): 224-226.
[12] 宋付民. 探究连续性血液净化应用在重症脓毒血症患者治疗中的临床价值[J]. 临床医药文献电子杂志, 2016, 3(34): 6752-6753.
[13] 闫笛, 宋岩, 谭博. 连续性血液净化疗法对重症脓毒血症患者疗效及炎症因子的影响[J]. 当代医学, 2017, 23(6): 27-28.
[14] 朱文秀. 高容量连续性血液净化治疗对脓毒血症致早期急性肾损伤的效果观察[J]. 医疗装备, 2016, 29(8): 148-149.
[15] 关纯, 王素梅, 辛雪琳. 脓毒血症连续性血液净化治疗及其护理干预评价[J]. 中国医药导刊, 2016, 18(7): 722-723.